Fischer Chemic - 2026 Company Profile, Team

About Fischer Chemic

Fischer Chemic is a publicly listed company based in Mumbai (India) founded in 1984. Laboratory chemicals are manufactured for research and industrial use. The company has 15 employees. Its Indian entity Fischer Medical Ventures Limited reported revenue of ₹321 Cr.

Company details

Fischer Chemic was established in 1984 in Mumbai, India, within the chemical manufacturing sector. Operations focus on the production of laboratory-grade chemicals, including reagents and solvents essential for scientific and industrial applications. The company maintains its headquarters and primary facilities in Mumbai, serving domestic and international markets through standard distribution channels. Core activities encompass formulation, quality control, and packaging of these specialized products to meet regulatory standards.

Headquarters Mumbai, India
Employees 15
Stage Public
Website fischerchemic.com
Social LinkedIn
Legal Name Fischer Medical Ventures Ltd

Key Metrics

Market Cap
₹1,768 Cr
FISCHER · NSE
Share Price
₹24.87
-1.74% today
Revenue
₹309 Cr
FY 2025-26 · +178.8% YoY
EBITDA
₹42.87 Cr
Margin 13.9%
Net Profit
₹31.03 Cr
FY 2025-26 · +1982.6% YoY
P/E (TTM)
71.7x
P/B 3.6x
Employee Count
15

Associated legal entities of Fischer Chemic

Fischer Chemic operates through Fischer Medical Ventures Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.

Legal entity	Status	Incorporated	Registered in	Revenue (FY 2026)	Employees	Directors	Company page
Fischer Medical Ventures Limited Listed CIN L86900AP1993PLC118162	Active	22 Mar 1993	Visakhapatnam, Andhra Pradesh	₹321 Cr	15	9	View details

Board of directors of Fischer Medical Ventures Limited (Fischer Chemic)

Fischer Medical Ventures Limited is the primary company behind Fischer Chemic. The board of Fischer Medical Ventures Limited currently have 7 directors; the longest-serving is Khairy Jamaluddin Abu Bakar, appointed in 2024. 29 earlier directors have ceased.

Director	Designation	Appointed	Tenure	Entity
Khairy Jamaluddin Abu Bakar DIN 10612234	Director	04 May 2024	2 yrs 6 mo	Fischer Medical Ventures Limited
Svetlana Rao Raviwada DIN 06899295	Whole-time director	04 May 2024	2 yrs 6 mo	Fischer Medical Ventures Limited
Ravindran Govindan DIN 03137661	Managing Director	04 May 2024	2 yrs 6 mo	Fischer Medical Ventures Limited
Jaya Ankur Singhania DIN 01990322	Director	26 Mar 2025	1 yr 7 mo	Fischer Medical Ventures Limited
Chan Sing En DIN 11300541	Director	28 Oct 2025	1 yr	Fischer Medical Ventures Limited
Syed Jalaludin DIN 11336135	Director	30 Nov 2025	11 mo	Fischer Medical Ventures Limited
David Yeow Kok Hee DIN 11923054	Director	03 Sep 2026	2 mo	Fischer Medical Ventures Limited

IPO & Listings of Fischer Chemic

Fischer Chemic is a publicly listed company on the NSE with ticker symbol FISCHER in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

IPO date17 Sep 2010
Listed onBSE: 524743
Listed entityFischer Medical Ventures Ltd
Exchange sectorProcess industries
ISININE771F01041
Share price₹29.59 (-1.53% on the day) · 2026-10-14
Market capitalisation₹1,969 Cr
Price to earnings66.4
EPS (diluted, trailing year)₹0.45
Dividend yield0.17%
Volume (last session)358,810

Financials of Fischer Chemic

Exchange-reported figures of Fischer Medical Ventures Limited, the listed company behind Fischer Chemic (NSE: FISCHER).

Financial Highlights

FY 2025-26 · Consolidated

Revenue

₹309 Cr

+178.8% YoY

EBITDA

₹42.87 Cr

+1399.0% YoY

Profit After Tax

₹31.03 Cr

+1982.6% YoY

Net Worth

₹385 Cr

+14.0% YoY

Total Assets

₹493 Cr

+16.5% YoY

Total Debt

₹107 Cr

+25.4% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Income statement
Revenue	309	111	20.98	0.18
Revenue growth	+178.8%	+427.7%	-	-
EBITDA	42.87	2.86	1.85	0.02
EBITDA margin	+13.9%	+2.6%	+8.8%	+11.1%
Profit before tax	46.37	2.23	2.10	0.00
Net profit	31.03	1.49	1.37	(0.04)
Net profit margin	+10.1%	+1.4%	+6.5%	-22.2%
EPS (₹)	0.44	0.23	0.26	(2.12)
Balance sheet
Total assets	493	423	82.79	0.31
Net worth	385	338	81.11	(0.27)
Total debt	107	85.37	1.68	0.57
Cash & bank	25.05	251	37.95	0.04
Net working capital	240	332	67.00	0.21
Cash flow
Cash from operations	(101)	(86.25)	(7.35)	-
Cash from investing	(5.22)	(125)	(28.79)	-
Cash from financing	14.11	315	37.06	-

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	81.92	97.54	101	86.31	23.44	49.17	11.75	39.66
Revenue growth (YoY)	+249.5%	+98.4%	+760.4%	+117.6%	+131.6%	-	-	-
Other income	1.48	0.77	1.09	2.48	7.47	0.15	0.38	0.22
EBITDA	11.25	(3.76)	21.57	16.22	3.99	2.50	0.37	0.33
EBITDA margin	+13.7%	-3.9%	+21.3%	+18.8%	+17.0%	+5.1%	+3.1%	+0.8%
Depreciation	1.36	0.93	0.77	0.51	0.77	0.51	0.56	0.29
Interest	3.54	3.66	0.64	0.92	0.66	0.23	0.07	0.05
Profit before tax	7.83	(7.58)	21.25	17.27	10.03	1.91	0.12	0.21
Tax	4.04	4.86	1.95	3.36	5.17	0.50	0.42	(0.08)
Net profit	3.79	(12.44)	19.30	13.91	4.86	1.41	(0.30)	0.29
EPS (₹)	0.05	(0.18)	0.29	0.21	0.07	(0.05)	(0.05)	0.05

Metrics	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Income statement
Revenue	17.39	5.22	11.53	0.18	0.00	0.17	0.18
Revenue growth	+233.1%	-54.7%	+6305.6%	-	-100.0%	-5.6%	-
EBITDA	(8.67)	(2.24)	(0.19)	0.02	(0.19)	(0.01)	(0.03)
EBITDA margin	-49.9%	-42.9%	-1.7%	+11.1%	-	-5.9%	-16.7%
Profit before tax	(10.51)	0.96	0.54	0.00	(0.20)	(0.03)	(0.05)
Net profit	(10.43)	0.67	0.40	(0.04)	(0.24)	0.15	(0.05)
Net profit margin	-60.0%	+12.8%	+3.5%	-22.2%	-	+88.2%	-27.8%
EPS (₹)	(0.15)	0.10	0.08	(2.12)	(13.52)	8.17	(2.39)
Balance sheet
Total assets	384	358	79.68	0.31	0.16	0.24	0.08
Net worth	338	336	79.68	(0.27)	(0.23)	0.00	(0.14)
Total debt	45.65	22.08	0.00	0.57	0.39	0.23	0.22
Cash & bank	1.14	0.29	0.00	0.04	0.02	0.04	0.10
Net working capital	24.81	26.81	38.38	0.21	0.02	0.05	0.07
Cash flow
Cash from operations	(2.91)	(22.81)	0.08	(0.15)	(0.18)	(0.06)	0.01
Cash from investing	(13.27)	(232)	(37.78)	0.00	0.00	0.00	0.00
Cash from financing	17.02	255	37.67	0.17	0.15	0.00	0.00

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	0.72	4.11	1.32	7.43	4.54	5.22	0.00	0.00
Revenue growth (YoY)	-84.1%	-21.3%	-	-	-	-	-	-
Other income	0.89	0.43	0.86	1.43	0.80	0.65	0.87	0.82
Total expenses	2.60	13.01	2.63	6.28	4.17	6.78	0.22	0.36
EBITDA	(1.88)	(8.90)	(1.31)	1.15	0.37	(1.56)	(0.22)	(0.36)
EBITDA margin	-261.1%	-216.5%	-99.2%	+15.5%	+8.1%	-29.9%	-	-
Depreciation	0.77	0.43	0.08	0.08	0.08	0.10	0.03	0.00
Interest	1.47	1.27	0.96	1.12	1.31	0.12	0.00	0.00
Profit before tax	(3.23)	(10.17)	(1.49)	1.38	(0.22)	(1.13)	0.62	0.46
Tax	0.27	(1.19)	0.17	0.54	0.39	(0.24)	0.42	(0.05)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 15 Nov 2026

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	81.92	97.54	101	86.31	23.44	49.17	11.75	39.66
Revenue growth (YoY)	+249.5%	+98.4%	+760.4%	+117.6%	+131.6%	-	-	-
Other income	1.48	0.77	1.09	2.48	7.47	0.15	0.38	0.22
EBITDA	11.25	(3.76)	21.57	16.22	3.99	2.50	0.37	0.33
EBITDA margin	+13.7%	-3.9%	+21.3%	+18.8%	+17.0%	+5.1%	+3.1%	+0.8%
Depreciation	1.36	0.93	0.77	0.51	0.77	0.51	0.56	0.29
Interest	3.54	3.66	0.64	0.92	0.66	0.23	0.07	0.05
Profit before tax	7.83	(7.58)	21.25	17.27	10.03	1.91	0.12	0.21
Tax	4.04	4.86	1.95	3.36	5.17	0.50	0.42	(0.08)
Net profit	3.79	(12.44)	19.30	13.91	4.86	1.41	(0.30)	0.29
EPS (₹)	0.05	(0.18)	0.29	0.21	0.07	(0.05)	(0.05)	0.05

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Revenue	309	111	20.98	0.18
Revenue growth	+178.8%	+427.7%	-	-
Other income	12.31	1.49	0.50	0.00
Total expenses	266	108	19.13	0.16
Employee cost	0.00	2.48	0.38	0.05
EBITDA	42.87	2.86	1.85	0.02
EBITDA margin	+13.9%	+2.6%	+8.8%	+11.1%
Depreciation	2.98	1.63	0.18	0.00
Interest	5.83	0.49	0.07	0.02
Profit before tax	46.37	2.23	2.10	0.00
Tax	15.34	1.01	0.27	0.04
Net profit	31.03	1.49	1.37	(0.04)
Net profit margin	+10.1%	+1.4%	+6.5%	-22.2%
EPS (₹)	0.44	0.23	0.26	(2.12)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Equity & liabilities
Share capital	65.45	63.80	53.50	0.17
Reserves & surplus	320	274	26.74	(0.44)
Shareholders' funds (net worth)	385	338	81.11	(0.27)
Minority interest	0.00	0.00	0.00	0.00
Secured loans	8.79	0.00	0.00	0.00
Unsecured loans	98.29	85.37	1.68	0.57
Total debt	107	85.37	1.68	0.57
Total liabilities	493	423	82.79	0.31
Assets
Gross block	37.52	26.72	15.93	0.00
Net block	31.68	23.88	14.71	0.00
Capital work in progress	2.93	1.11	0.00	0.00
Investments	118	6.95	1.21	0.00
Inventories	12.66	9.16	4.48	0.00
Sundry debtors	289	76.07	22.87	0.17
Cash & bank balances	25.05	251	37.95	0.04
Loans & advances	91.08	28.70	5.11	0.04
Total current assets	418	365	70.41	0.25
Total current liabilities	178	33.68	3.41	0.04
Net working capital	240	332	67.00	0.21
Total assets	493	423	82.79	0.31

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Opening cash	104	0.95	0.04	-
Net cash from operating activities	(101)	(86.25)	(7.35)	-
Net cash from investing activities	(5.22)	(125)	(28.79)	-
Net cash from financing activities	14.11	315	37.06	-
Net change in cash	(92.37)	103	0.91	-
Closing cash	25.05	251	37.95	-

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23
Growth
Sales growth	+178.8%	+427.7%	-	-
EBITDA growth	+1399.0%	+54.6%	+9150.0%	-
PBT growth	+1979.4%	+6.2%	+9997.0%	+9997.0%
Net income growth	+1982.6%	+8.8%	+3525.0%	-
Revenue CAGR (3Y)	+1096.8%	-	-	-
EBITDA CAGR (3Y)	+1189.4%	-	-	-
Profitability & leverage
Net income margin	+10.1%	+1.1%	+8.7%	-22.2%
Return on capital employed	-	+1.1%	+5.3%	0.0%
Return on net worth	-	+0.6%	+4.6%	0.0%
Debt / equity	-	0.21	0.03	0.00
Long-term debt / equity	-	0.04	0.02	0.00
Interest cover	14.62	39.84	4.19	100.00
Efficiency & per share
Fixed asset turnover	-	5.19	2.63	0.00
Inventory turnover	-	16.23	9.37	0.00
Debtors turnover	-	2.24	1.82	1.06
EPS (₹)	0.44	0.23	0.26	(2.12)
Dividend per share (₹)	0.05	0.05	0.00	0.00
Book value per share (₹)	0.00	48.17	15.00	(15.47)

Particulars	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Revenue	0.72	4.11	1.32	7.43	4.54	5.22	0.00	0.00
Revenue growth (YoY)	-84.1%	-21.3%	-	-	-	-	-	-
Other income	0.89	0.43	0.86	1.43	0.80	0.65	0.87	0.82
Total expenses	2.60	13.01	2.63	6.28	4.17	6.78	0.22	0.36
EBITDA	(1.88)	(8.90)	(1.31)	1.15	0.37	(1.56)	(0.22)	(0.36)
EBITDA margin	-261.1%	-216.5%	-99.2%	+15.5%	+8.1%	-29.9%	-	-
Depreciation	0.77	0.43	0.08	0.08	0.08	0.10	0.03	0.00
Interest	1.47	1.27	0.96	1.12	1.31	0.12	0.00	0.00
Profit before tax	(3.23)	(10.17)	(1.49)	1.38	(0.22)	(1.13)	0.62	0.46
Tax	0.27	(1.19)	0.17	0.54	0.39	(0.24)	0.42	(0.05)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Revenue	17.39	5.22	11.53	0.18	0.00	0.17	0.18
Revenue growth	+233.1%	-54.7%	+6305.6%	-	-100.0%	-5.6%	-
Other income	3.49	3.46	0.75	0.00	0.00	0.00	0.00
Total expenses	26.06	7.46	11.72	0.16	0.19	0.18	0.21
Employee cost	0.00	0.13	0.06	0.05	0.08	0.08	0.09
EBITDA	(8.67)	(2.24)	(0.19)	0.02	(0.19)	(0.01)	(0.03)
EBITDA margin	-49.9%	-42.9%	-1.7%	+11.1%	-	-5.9%	-16.7%
Depreciation	0.68	0.13	0.00	0.00	0.00	0.00	0.00
Interest	4.65	0.13	0.02	0.02	0.01	0.02	0.02
Profit before tax	(10.51)	0.96	0.54	0.00	(0.20)	(0.03)	(0.05)
Tax	(0.08)	0.29	0.14	0.04	0.04	(0.18)	0.00
Net profit	(10.43)	0.67	0.40	(0.04)	(0.24)	0.15	(0.05)
Net profit margin	-60.0%	+12.8%	+3.5%	-22.2%	-	+88.2%	-27.8%
EPS (₹)	(0.15)	0.10	0.08	(2.12)	(13.52)	8.17	(2.39)

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Equity & liabilities
Share capital	65.45	63.80	53.50	0.17	0.17	0.17	0.17
Reserves & surplus	247	242	25.31	(0.44)	(0.40)	(0.17)	(0.31)
Shareholders' funds (net worth)	338	336	79.68	(0.27)	(0.23)	0.00	(0.14)
Secured loans	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured loans	45.65	22.08	0.00	0.57	0.39	0.23	0.22
Total debt	45.65	22.08	0.00	0.57	0.39	0.23	0.22
Total liabilities	384	358	79.68	0.31	0.16	0.24	0.08
Assets
Gross block	12.07	0.78	0.01	0.00	0.00	0.00	0.00
Net block	11.37	0.68	0.01	0.00	0.00	0.00	0.00
Capital work in progress	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	304	291	41.28	0.00	0.00	0.00	0.00
Inventories	0.42	0.07	0.00	0.00	0.00	0.00	0.00
Sundry debtors	20.71	17.08	12.70	0.17	0.00	0.00	0.00
Cash & bank balances	1.14	0.29	0.00	0.04	0.02	0.04	0.10
Loans & advances	7.31	10.11	37.83	0.04	0.03	0.03	0.03
Total current assets	29.58	27.55	50.53	0.25	0.05	0.07	0.13
Total current liabilities	4.77	0.74	12.15	0.04	0.03	0.02	0.06
Net working capital	24.81	26.81	38.38	0.21	0.02	0.05	0.07
Total assets	384	358	79.68	0.31	0.16	0.24	0.08

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Opening cash	0.29	0.00	0.04	0.02	0.04	0.10	0.09
Net cash from operating activities	(2.91)	(22.81)	0.08	(0.15)	(0.18)	(0.06)	0.01
Net cash from investing activities	(13.27)	(232)	(37.78)	0.00	0.00	0.00	0.00
Net cash from financing activities	17.02	255	37.67	0.17	0.15	0.00	0.00
Net change in cash	0.85	0.28	(0.03)	0.02	(0.03)	(0.06)	0.01
Closing cash	1.14	0.29	0.00	0.04	0.02	0.04	0.10

Particulars	FY 2025-26	FY 2024-25	FY 2023-24	FY 2022-23	FY 2021-22	FY 2020-21	FY 2019-20
Growth
Sales growth	+233.1%	-54.7%	+6305.6%	-	-100.0%	-5.6%	-
EBITDA growth	-287.1%	-1079.0%	-1050.0%	+110.5%	-1800.0%	+66.7%	-
PBT growth	-	+77.8%	+9997.0%	+9997.0%	-566.7%	+40.0%	-
Net income growth	-1656.7%	+67.5%	+1100.0%	+83.3%	-260.0%	+400.0%	-
Revenue CAGR (3Y)	+358.9%	-	+307.8%	0.0%	-	-	-
EBITDA CAGR (3Y)	-	+127.6%	+166.8%	-	+1.8%	-63.2%	-38.7%
Profitability & leverage
Net income margin	-60.0%	+12.8%	+3.5%	-22.2%	-	+88.2%	-27.8%
Return on capital employed	-	+0.5%	+1.4%	0.0%	0.0%	-6.4%	0.0%
Return on net worth	-	+0.3%	+1.0%	0.0%	0.0%	+155.6%	0.0%
Debt / equity	-	0.05	0.01	0.00	0.00	0.00	0.00
Long-term debt / equity	-	0.04	0.00	0.00	0.00	0.00	0.00
Interest cover	-49.73	-5.49	-10.53	100.00	-5.26	-200.00	-66.67
Efficiency & per share
Fixed asset turnover	-	13.05	2,306.00	0.00	0.00	0.00	0.00
Inventory turnover	-	149.14	0.00	0.00	0.00	0.00	0.00
Debtors turnover	-	0.35	1.79	2.12	0.00	0.00	0.00
EPS (₹)	(0.15)	0.10	0.08	(2.12)	(13.52)	8.17	(2.39)
Dividend per share (₹)	0.05	0.05	0.00	0.00	0.00	0.00	0.00
Book value per share (₹)	0.00	47.88	14.73	(15.47)	(13.34)	0.18	(7.99)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.

Included in your Premium account

✓
Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
✓
Full access to every database India & global coverage, advanced filters and rich profile details
✓
Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fischer Chemic

Fischer Medical Ventures: Approves ₹50 Crore Investment for Three Subsidiary Rights Issues

Exchange Update • 1 month ago

Fischer Medical Ventures Unit Awarded Province-Wide Digital Healthcare Project In Catanduanes

Reuters • 2 months ago

Fischer Medical Ventures consolidated net profit declines 22.02% in the June 2026 quarter | Capital Market News - Business Standard

Business Standard • 3 months ago

Fischer Medical Ventures Unit Receives CDSCO Import Approval For Portable Wound Care System

Reuters • 3 months ago

Fischer Medical Ventures' Unit Gets Order Worth $6.5 Million In Indonesia

Reuters • 11 months ago

Fischer Medical Ventures Says Unit Announces New Low-Field TOF MRI Platform

Reuters • 12 months ago

Fischer Medical Ventures - Awarded 92.9 Million Rupees Order

Reuters • 1 year ago

Fischer Medical Ventures Province Of Bulacan Inaugurates Mri Facility Developed By Time Medical

Reuters • 1 year ago

Eimco Elecon (India) Ltd leads losers in 'B' group | Capital Market News - Business Standard

Business Standard • 1 year ago

Fischer Medical Ventures consolidated net profit declines 42.08% in the March 2025 quarter | Capital Market News - Business Standard

Business Standard • 1 year ago

Premium access

Complete news archive for Fischer Chemic

Full article history, source details, and older brand coverage require an active premium plan.

Full article archive
Source and publication date
Older coverage
Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fischer Chemic

When was Fischer Chemic founded?

Fischer Chemic was founded in 1984.

Where is Fischer Chemic located?

Fischer Chemic is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

How many employees does Fischer Chemic have?

Fischer Chemic has 15 employees.

What is the annual revenue of Fischer Chemic?

The primary company behind Fischer Chemic, Fischer Medical Ventures Limited, reported revenue of ₹321 Cr for FY 2026, up 179% year on year.

What does Fischer Chemic do?

Fischer Chemic was established in 1984 in Mumbai, India, within the chemical manufacturing sector. Operations focus on the production of laboratory-grade chemicals, including reagents and solvents essential for scientific and industrial applications. The company maintains its headquarters and primary facilities in Mumbai, serving domestic and international markets through standard distribution channels. Core activities encompass formulation, quality control, and packaging of these specialized products to meet regulatory standards.

Is Fischer Chemic publicly traded?

Yes, Fischer Chemic is publicly traded on NSE under the ticker symbol FISCHER.

Which legal entities are associated with Fischer Chemic?

Fischer Chemic operates through Fischer Medical Ventures Limited.

Who are the directors of Fischer Chemic?

The legal entities of Fischer Chemic currently have 9 directors, including Syed Jalaludin, Chan Sing En, Jaya Ankur Singhania and others.